SUCEF(SUCEF)
SUCEF
No analyst ratings available
No analyst price targets available for SUCEF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $238.37B | $257.49B | $271.44B | $277.26B | $282.52B |
| Low | $236.45B | $254.07B | $268.52B | $274.27B | $279.47B |
| High | $241.01B | $260.25B | $274.39B | $280.27B | $285.59B |
| EBITDA Avg | $39.57B | $49.19B | $56.43B | $60.98B | $62.70B |
| Low | $39.38B | $48.89B | $56.05B | $60.56B | $62.28B |
| High | $39.75B | $49.49B | $56.81B | $61.40B | $63.13B |
| EBIT Avg | $14.34B | $22.30B | $27.84B | $30.88B | $31.25B |
| Low | $14.15B | $22.00B | $27.46B | $30.46B | $30.83B |
| High | $14.52B | $22.59B | $28.21B | $31.30B | $31.68B |
| Net Income Avg | $10.70B | $17.12B | $21.59B | $24.04B | $24.35B |
| Low | $10.55B | $16.88B | $21.29B | $23.70B | $24.00B |
| High | $10.85B | $17.36B | $21.89B | $24.38B | $24.69B |
| EPS Avg | $333.54 | $533.68 | $673.00 | $749.40 | $758.92 |
| Low | $328.86 | $526.19 | $663.56 | $738.89 | $748.28 |
| High | $338.25 | $541.21 | $682.50 | $759.98 | $769.63 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $58.35B | $62.78B | $62.17B |
| Low | $57.92B | $62.28B | $61.69B |
| High | $58.91B | $63.39B | $62.77B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — | 1 / — |